Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Astatine
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Formation === <div style="float: left; margin: 0 1em 0 0; font-size: 90%;"> {| class="wikitable" |+ Possible reactions after bombarding bismuth-209 with alpha particles !rowspan=2| Reaction{{efn|A nuclide is commonly denoted by a symbol of the chemical element this nuclide belongs to, <!--if someone can come up with a better wording, please do, or, if you think it's okay, just remove this message--> preceded by a non-spaced superscript mass number and a subscript atomic number of the nuclide located directly under the mass number. (Neutrons may be considered as nuclei with the atomic mass of 1 and the atomic charge of 0, with the symbol being n.) With the atomic number omitted, it is also sometimes used as a designation of an isotope of an element in isotope-related chemistry.}} !colspan=2| Energy of alpha particle |- ! Threshold energy ! Maximum production |- | style="text-align:center;"| {{chem|209|83|Bi}} + {{chem|4|2|He}} → {{chem|211|85|At}} + 2 {{chem|1|0}}n | style="text-align:center;"| 20.7 MeV<ref name="Hermanne"/> | style="text-align:center;"| 30<ref name="Gyehong"/>–31 MeV<ref name="Hermanne"/> |- | style="text-align:center;"| {{chem|209|83|Bi}} + {{chem|4|2|He}} → {{chem|210|85|At}} + 3 {{chem|1|0}}n | style="text-align:center;"| 28.4<ref name="zalutsky"/>–28.6 MeV<ref name="Hermanne"/><ref name="Maiti"/> | style="text-align:center;"| 37 MeV<ref name="Hermanne">{{cite journal | last1=Hermanne | first1=A. | last2=Tárkányi | first2=F. | last3=Takács | first3=S. | last4=Szücs | first4=Z. | last5=Shubin | first5=Yu.N. | last6=Dityuk | first6=A.I. | title=Experimental study of the cross-sections of α-particle induced reactions on 209Bi | journal=Applied Radiation and Isotopes | publisher=Elsevier BV | volume=63 | issue=1 | year=2005 | issn=0969-8043 | doi=10.1016/j.apradiso.2005.01.015 | pages=1–9}}</ref> |- | style="text-align:center;"| {{chem|209|83|Bi}} + {{chem|4|2|He}} → {{chem|209|85|At}} + 4 {{chem|1|0}}n | style="text-align:center;"| 35.9 MeV<ref name="Maiti">{{cite journal | last1=Maiti | first1=Moumita | last2=Lahiri | first2=Susanta | last3=Kumar | first3=Deepak | last4=Choudhury | first4=Dibyasree | title=Separation of no-carrier-added astatine radionuclides from α-particle irradiated lead bismuth eutectic target: A classical method | journal=Applied Radiation and Isotopes | publisher=Elsevier BV | volume=127 | year=2017 | issn=0969-8043 | doi=10.1016/j.apradiso.2017.06.020 | pages=227–230| pmid=28649020 | bibcode=2017AppRI.127..227M }}</ref> | style="text-align:center;"| |} </div> [[File:Astatine-211 in bismuth target.jpg|thumb|left|The bismuth target after irradiation contains minuscule quantities of astatine-211.<ref>{{cite journal | last1=Naka | first1=Sadahiro | last2=Ooe | first2=Kazuhiro | last3=Shirakami | first3=Yoshifumi | last4=Kurimoto | first4=Kenta | last5=Sakai | first5=Toshihiro | last6=Takahashi | first6=Kazuhiro | last7=Toyoshima | first7=Atsushi | last8=Wang | first8=Yang | last9=Haba | first9=Hiromitsu | last10=Kato | first10=Hiroki | last11=Tomiyama | first11=Noriyuki | last12=Watabe | first12=Tadashi | title=Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial | journal=EJNMMI Radiopharmacy and Chemistry | volume=9 | issue=1 | date=2024-04-15 | issn=2365-421X | pmid=38619655 | pmc=11018728 | doi=10.1186/s41181-024-00257-z | doi-access=free}}</ref>]] Astatine was first produced by bombarding bismuth-209 with energetic alpha particles, and this is still the major route used to create the relatively long-lived isotopes astatine-209 through astatine-211. Astatine is only produced in minuscule quantities, with modern techniques allowing production runs of up to 6.6 [[gigabecquerel]]s<ref name="zalutsky"/> (about 86 [[nanogram]]s or 2.47{{e|14}} atoms). Synthesis of greater quantities of astatine using this method is constrained by the limited availability of suitable cyclotrons and the prospect of melting the target.<ref name="zalutsky"/><ref name="Larsen" />{{efn|See however Nagatsu et al.<ref>{{cite journal |first1=K.|last1=Nagatsu|first2=K. H.|last2=Minegishi|first3=M. |last3=Fukada |first4=H. |last4=Suzuki |first5=S.|last5=Hasegawa |first6=M. |last6=Zhang|year=2014 |title=Production of <sup>211</sup>At by a vertical beam irradiation method|journal=Applied Radiation and Isotopes |volume=94 |pages=363–371 |doi=10.1016/j.apradiso.2014.09.012|pmid=25439168|bibcode=2014AppRI..94..363N }}</ref> who encapsulate the bismuth target in a thin aluminium foil and place it in a niobium holder capable of holding molten bismuth.}} Solvent [[radiolysis]] due to the cumulative effect of astatine decay<ref>{{cite book | title = Therapeutic Nuclear Medicine| year = 2014 | pages = 95–104 (99) | publisher = Springer | isbn = 978-3-540-36718-5 | last1 = Barbet | first1 = J. | last2 = Bourgeois | first2 = M.|first3= J.|last3= Chatal|editor1 = R. P.|editor2 = Baum|chapter= Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy}}</ref> is a related problem. With cryogenic technology, [[microgram]] quantities of astatine might be able to be generated via proton irradiation of [[thorium]] or [[uranium]] to yield radon-211, in turn decaying to astatine-211. Contamination with astatine-210 is expected to be a drawback of this method.<ref name="Wilbur">{{cite journal | last = Wilbur| first = D. S. | date = 2001| title = Overcoming the Obstacles to Clinical Evaluation of <sup>211</sup>At-Labeled Radiopharmaceuticals | journal = The Journal of Nuclear Medicine | volume = 42 | issue = 10 | pages = 1516–1518 | url=http://jnm.snmjournals.org/content/42/10/1516|pmid=11585866}}</ref> The most important isotope is astatine-211, the only one in commercial use. To produce the bismuth target, the metal is [[sputtering|sputtered]] onto a gold, copper, or aluminium surface at 50 to 100 milligrams per square centimeter. [[Bismuth oxide]] can be used instead; this is forcibly fused with a copper plate.{{sfn|Lavrukhina|Pozdnyakov|1970|p=233}} The target is kept under a [[Nitrogen gas#Reactions|chemically neutral nitrogen]] atmosphere,<ref name="BiN2">{{cite book|title=Inorganic Chemistry for Undergraduates|first=R. |last=Gopalan |year=2009|page=547|publisher=Universities Press | isbn = 978-81-7371-660-7 | url = https://books.google.com/books?id=Fs4zQ-hNTz8C&pg=PA492}}</ref> and is cooled with water to prevent premature astatine vaporization.{{sfn|Lavrukhina|Pozdnyakov|1970|p=233}} In a particle accelerator, such as a cyclotron,<ref>{{cite book|title=Targeted Radionuclide Tumor Therapy: Biological Aspects|first1=T.|last1=Stigbrand |first2=J. |last2=Carlsson |first3=G. P.|last3=Adams|year=2008|page=150|publisher=Springer | isbn = 978-1-4020-8695-3 | url = https://books.google.com/books?id=-mT0Lthq_54C}}</ref> alpha particles are collided with the bismuth. Even though only one bismuth isotope is used (bismuth-209), the reaction may occur in three possible ways, producing astatine-209, astatine-210, or astatine-211. Although higher energies can produce more astatine-211, it will produce unwanted astatine-210 that decays to toxic polonium-210 as well. Instead, the maximum energy of the particle accelerator is set to be below or slightly above the threshold of astatine-210 production, in order to maximize the production of astatine-211 while keeping the amount of astatine-210 at an acceptable level.<ref name="zalutsky"/><ref name="Gyehong">{{cite journal |first1=G.|last1=Gyehong |first2=K.|last2=Chun|first3=S. H. |last3=Park |first4=B.|last4=Kim|year=2014 |title=Production of α-particle emitting <sup>211</sup>At using 45 MeV α-beam| journal=Physics in Medicine and Biology |volume=59 |issue=11|pages=2849–2860| doi=10.1088/0031-9155/59/11/2849|pmid=24819557 |bibcode = 2014PMB....59.2849K |s2cid=21973246 }}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Astatine
(section)
Add topic